Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid

Joyce Steinberg, Charles Erlichman, Tahany Gadalla, Sheldon Fine, Alfred Wong

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

We have reported that 5-fluorouracil (5-FU) and folinic acid increased response rate and survival in patients with metastatic colorectal cancer. Now we have analysed prognostic factors for response, toxicity, survival and time to progression. The variables used for survival and response were treatment centre, treatment, age, sex, Eastern Cooperative Oncology Group (ECOG) performance status (PS), site of disease, previous radiotherapy, site of primary, disease-free interval, initial alkaline phosphatase (AP), albumin (A), lactate dehydrogenase (LDH) and aspartate aminotransferase (SGOT). The significant independent variables for survival were PS of 2 or more, initial albumin and SGOT, and treatment received, in order of importance. The relative risk of death when patients received 5-FU/folinic acid was 60% of that of patients receiving 5-FU alone. The variables predictive of response were treatment and PS. The variables used for analysis of toxicity were age, treatment centre, treatment, sex, tumour response, PS, number of courses, SGOT, AP and albumin. Treatment was found to be predictive of toxicity. Thus, baseline albumin and SGOT, and 5-FU/folinic acid treatment are significant determinats of survival, 5-FU/folinic acid and PS of 2 or more are major determinants of response and no clinical parameter could be identified as a predictor of toxicity.

Original languageEnglish (US)
Pages (from-to)1817-1820
Number of pages4
JournalEuropean Journal of Cancer
Volume28
Issue number11
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Leucovorin
Fluorouracil
Colorectal Neoplasms
Aspartate Aminotransferases
Albumins
Survival
Therapeutics
Alkaline Phosphatase
L-Lactate Dehydrogenase
Radiotherapy
Survival Rate

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. / Steinberg, Joyce; Erlichman, Charles; Gadalla, Tahany; Fine, Sheldon; Wong, Alfred.

In: European Journal of Cancer, Vol. 28, No. 11, 1992, p. 1817-1820.

Research output: Contribution to journalArticle

Steinberg, Joyce ; Erlichman, Charles ; Gadalla, Tahany ; Fine, Sheldon ; Wong, Alfred. / Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. In: European Journal of Cancer. 1992 ; Vol. 28, No. 11. pp. 1817-1820.
@article{36080311c5064a7b9d1b886ee05580fd,
title = "Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid",
abstract = "We have reported that 5-fluorouracil (5-FU) and folinic acid increased response rate and survival in patients with metastatic colorectal cancer. Now we have analysed prognostic factors for response, toxicity, survival and time to progression. The variables used for survival and response were treatment centre, treatment, age, sex, Eastern Cooperative Oncology Group (ECOG) performance status (PS), site of disease, previous radiotherapy, site of primary, disease-free interval, initial alkaline phosphatase (AP), albumin (A), lactate dehydrogenase (LDH) and aspartate aminotransferase (SGOT). The significant independent variables for survival were PS of 2 or more, initial albumin and SGOT, and treatment received, in order of importance. The relative risk of death when patients received 5-FU/folinic acid was 60{\%} of that of patients receiving 5-FU alone. The variables predictive of response were treatment and PS. The variables used for analysis of toxicity were age, treatment centre, treatment, sex, tumour response, PS, number of courses, SGOT, AP and albumin. Treatment was found to be predictive of toxicity. Thus, baseline albumin and SGOT, and 5-FU/folinic acid treatment are significant determinats of survival, 5-FU/folinic acid and PS of 2 or more are major determinants of response and no clinical parameter could be identified as a predictor of toxicity.",
author = "Joyce Steinberg and Charles Erlichman and Tahany Gadalla and Sheldon Fine and Alfred Wong",
year = "1992",
doi = "10.1016/0959-8049(92)90011-P",
language = "English (US)",
volume = "28",
pages = "1817--1820",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "11",

}

TY - JOUR

T1 - Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid

AU - Steinberg, Joyce

AU - Erlichman, Charles

AU - Gadalla, Tahany

AU - Fine, Sheldon

AU - Wong, Alfred

PY - 1992

Y1 - 1992

N2 - We have reported that 5-fluorouracil (5-FU) and folinic acid increased response rate and survival in patients with metastatic colorectal cancer. Now we have analysed prognostic factors for response, toxicity, survival and time to progression. The variables used for survival and response were treatment centre, treatment, age, sex, Eastern Cooperative Oncology Group (ECOG) performance status (PS), site of disease, previous radiotherapy, site of primary, disease-free interval, initial alkaline phosphatase (AP), albumin (A), lactate dehydrogenase (LDH) and aspartate aminotransferase (SGOT). The significant independent variables for survival were PS of 2 or more, initial albumin and SGOT, and treatment received, in order of importance. The relative risk of death when patients received 5-FU/folinic acid was 60% of that of patients receiving 5-FU alone. The variables predictive of response were treatment and PS. The variables used for analysis of toxicity were age, treatment centre, treatment, sex, tumour response, PS, number of courses, SGOT, AP and albumin. Treatment was found to be predictive of toxicity. Thus, baseline albumin and SGOT, and 5-FU/folinic acid treatment are significant determinats of survival, 5-FU/folinic acid and PS of 2 or more are major determinants of response and no clinical parameter could be identified as a predictor of toxicity.

AB - We have reported that 5-fluorouracil (5-FU) and folinic acid increased response rate and survival in patients with metastatic colorectal cancer. Now we have analysed prognostic factors for response, toxicity, survival and time to progression. The variables used for survival and response were treatment centre, treatment, age, sex, Eastern Cooperative Oncology Group (ECOG) performance status (PS), site of disease, previous radiotherapy, site of primary, disease-free interval, initial alkaline phosphatase (AP), albumin (A), lactate dehydrogenase (LDH) and aspartate aminotransferase (SGOT). The significant independent variables for survival were PS of 2 or more, initial albumin and SGOT, and treatment received, in order of importance. The relative risk of death when patients received 5-FU/folinic acid was 60% of that of patients receiving 5-FU alone. The variables predictive of response were treatment and PS. The variables used for analysis of toxicity were age, treatment centre, treatment, sex, tumour response, PS, number of courses, SGOT, AP and albumin. Treatment was found to be predictive of toxicity. Thus, baseline albumin and SGOT, and 5-FU/folinic acid treatment are significant determinats of survival, 5-FU/folinic acid and PS of 2 or more are major determinants of response and no clinical parameter could be identified as a predictor of toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0026660212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026660212&partnerID=8YFLogxK

U2 - 10.1016/0959-8049(92)90011-P

DO - 10.1016/0959-8049(92)90011-P

M3 - Article

VL - 28

SP - 1817

EP - 1820

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 11

ER -